These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 4448804)
41. [Preventive therapy in patients with recurrent kidney calculi]. Backman U; Danielson BG; Johansson G; Ljunghall S Lakartidningen; 1978 May; 75(19):1917-8. PubMed ID: 651452 [No Abstract] [Full Text] [Related]
42. Effect of the oral administration of ammonium chloride, sodium phosphate, cellulose phosphate and parathyroid extract on the activity product of brushite in urine. Pak CY; Cox JW; Powell E; Bartter FC Am J Med; 1971 Jan; 50(1):67-76. PubMed ID: 5539578 [No Abstract] [Full Text] [Related]
43. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi. Thomas WC Trans Am Clin Climatol Assoc; 1972; 83():113-24. PubMed ID: 5040108 [No Abstract] [Full Text] [Related]
44. Rational therapy of nephrolithiasis, Part II. Pak CY Ration Drug Ther; 1984 Dec; 18(12):1-7. PubMed ID: 6536978 [No Abstract] [Full Text] [Related]
45. Case report: moderate salt restriction for the management of hypertension and hypercalciuria. Saggar-Malik AK; Markandu ND; MacGregor GA; Cappuccio FP J Hum Hypertens; 1996 Dec; 10(12):811-3. PubMed ID: 9140787 [No Abstract] [Full Text] [Related]
46. [Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis]. Jaeger P; Portmann L; Bugnon JM; Jacquet AF; Burckhardt P Schweiz Med Wochenschr; 1982 Dec; 112(49):1795-8. PubMed ID: 7178877 [TBL] [Abstract][Full Text] [Related]
47. Use of phosphates in patients with calcareous renal calculi. Thomas WC Kidney Int; 1978 May; 13(5):390-6. PubMed ID: 351267 [No Abstract] [Full Text] [Related]
49. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction. Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269 [TBL] [Abstract][Full Text] [Related]
50. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal]. Serra A; Domingos F; Salgueiro C; Prata MM Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725 [TBL] [Abstract][Full Text] [Related]
51. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074 [TBL] [Abstract][Full Text] [Related]
58. Inorganic phosphates in the treatment of renal calculi. Thomas WC; Miller GH Mod Treat; 1967 May; 4(3):494-504. PubMed ID: 6045802 [No Abstract] [Full Text] [Related]
59. The effect of cellulose phosphate on intestinal absorption and urinary excretion of calcium. Some experience in its use in the treatment of calcium stone formation. Blacklock NJ; Macleod MA Br J Urol; 1974 Aug; 46(4):385-92. PubMed ID: 4416182 [No Abstract] [Full Text] [Related]
60. The effect of oral sodium phosphate on the formation of renal calculi and on idiopathic hypercalcuria. Bernstein DS; Newton R Lancet; 1966 Nov; 2(7473):1105-7. PubMed ID: 4162530 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]